Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 86
Filter
1.
Neuroscience ; 295: 139-50, 2015 Jun 04.
Article in English | MEDLINE | ID: mdl-25800307

ABSTRACT

Parkinson's disease (PD) is the most common neurodegenerative motor disorder in the world. The main causes of neurodegeneration in PD are mitochondrial impairment and oxidative stress promoted by dopamine (DA) metabolism in the cytosol. Protein l-isoaspartyl (d-aspartyl) methyltransferase (PIMT) is a protein repair enzyme with anti-apoptotic properties. We previously reported that PIMT was downregulated at both gene and protein levels by DA-induced oxidative stresses in SH-SY5Y neuroblastoma cells. The purpose of the current study was to investigate the anti-apoptotic function of PIMT toward DA-induced cell death to better understand its specific neuroprotective role. Overexpression of wild-type PIMT, in contrast to its inactive mutant, protected SH-SY5Y cells from cell death and caspase 3 activation upon DA treatments. The intrinsic pathway of apoptosis as measured by caspase 9 activity was triggered by reactive oxygen species produced from DA metabolism, and overexpression of wild-type PIMT completely prevented caspase 9 activity stimulated by DA. In addition, cells overexpressing wild-type PIMT produced significantly less reactive oxygen species despite DA treatment compared to cells that do not overexpress PIMT. Together, these data indicate that DA-associated PIMT downregulation is an important event contributing to neuronal cell death. More importantly, the PIMT anti-apoptotic capacity seems to be dependent on its involvement in the cellular antioxidant machinery.


Subject(s)
Apoptosis/drug effects , Dopamine/toxicity , Down-Regulation/genetics , Protein D-Aspartate-L-Isoaspartate Methyltransferase/metabolism , Caspases/metabolism , Cell Line, Tumor , Cell Survival/genetics , Down-Regulation/drug effects , Humans , Neuroblastoma/pathology , Point Mutation/genetics , Protein D-Aspartate-L-Isoaspartate Methyltransferase/genetics , Reactive Oxygen Species/metabolism , Transfection
2.
Neuroscience ; 267: 263-76, 2014 May 16.
Article in English | MEDLINE | ID: mdl-24631677

ABSTRACT

Parkinson's disease (PD) is a chronic and progressive neurological disorder that is characterized by the loss of dopaminergic neurons in the substantia nigra. Dopamine, via the oxidative stress that it generates in the cytosol, could contribute to the selective loss of neurons observed in PD. Protein L-isoaspartyl methyltransferase (PIMT) is an enzyme that repairs L-isoaspartyl-containing proteins and possesses anti-apoptotic properties. PIMT expression has been shown to decrease with age. Together, these observations prompted us to investigate whether dopamine can regulate PIMT expression in SH-SY5Y neuroblastoma cells. Here, we report that dopamine down-regulated PIMT at both gene and protein levels. The same inhibition of PIMT protein level was caused by the electron transport chain inhibitor, rotenone, which was accompanied, in both cases, by an increase in cell death and reactive oxygen species (ROS) production. In fact, pre-treatment with the antioxidant N-acetyl cysteine blocked PIMT dopamine-associated down-regulation. PCMT1 promoter mapping experiments allowed the identification of two regions that showed different sensitivity to DA action. A first region localized between 61 and 94bp upstream of transcription start site was very sensitive to dopamine inhibition while a second region between 41 and 61bp appeared more resistant to dopamine inhibitory effect. The inhibition of PCMT1 promoter activity was mediated by dopamine-induced ROS since it was prevented by the hydroxyl radical scavenger N,N'-dimethylthiourea. Conversely, H2O2 inhibited in a dose-dependent manner the transcriptional activity of PCMT1 promoter. Therefore, our findings identified new molecular mechanisms, cytosolic dopamine and its resulting ROS, as inhibitors of PIMT expression. This suggests that ROS generated from cytosolic dopamine could reduce both the PCMT1 gene promoter activity and the PIMT protein level thus decreasing its capacity to repair proteins involved in apoptosis and could contribute to neuronal cell death observed in PD.


Subject(s)
Dopamine/pharmacology , Down-Regulation/drug effects , Protein D-Aspartate-L-Isoaspartate Methyltransferase/metabolism , Reactive Oxygen Species/metabolism , Antioxidants/pharmacology , Catalase/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Humans , Hydrogen Peroxide/pharmacology , Insecticides/pharmacology , Mutation/genetics , Neuroblastoma/pathology , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , Protein D-Aspartate-L-Isoaspartate Methyltransferase/genetics , RNA, Messenger/genetics , Receptors, Aryl Hydrocarbon/metabolism , Rotenone/pharmacology , Transfection
3.
Placenta ; 34(1): 85-8, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23177091

ABSTRACT

The syncytiotrophoblast is formed at the placental periphery through cytotrophoblast fusion, which depends on Human Endogenous Retrovirus-encoded Envelope proteins Syncytin-1 and Syncytin-2. In the current study, the role of Major Facilitator Superfamily Domain Containing 2A (MFSD2a), the Syncytin-2 receptor, in trophoblast fusion and its expression in normal vs. pre-eclampsia placentas were studied. Forskolin-induced fusion of BeWo cells first parallelled an increase in MFSD2a expression. The MFSD2a signal localized in the cytoplasm and at the plasma membrane. Knockdown of MFSD2a expression confirmed its importance in BeWo fusion. Furthermore, reduced MFSD2a expression was noted in severe pre-eclamptic placentas. These data thus support the importance of MFSD2a in trophoblast fusion and placenta development.


Subject(s)
Trophoblasts/physiology , Tumor Suppressor Proteins/physiology , Adult , Case-Control Studies , Cell Fusion , Cell Line , Female , Gene Expression Regulation/drug effects , Humans , Placenta/metabolism , Placenta/pathology , Pre-Eclampsia/genetics , Pre-Eclampsia/metabolism , Pre-Eclampsia/pathology , Pregnancy , Pregnancy Proteins/metabolism , RNA, Small Interfering/pharmacology , Receptors, Cytoplasmic and Nuclear/genetics , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Cytoplasmic and Nuclear/physiology , Symporters , Trophoblasts/drug effects , Trophoblasts/metabolism , Tumor Suppressor Proteins/antagonists & inhibitors , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
4.
Oncogene ; 27(9): 1253-62, 2008 Feb 21.
Article in English | MEDLINE | ID: mdl-17873913

ABSTRACT

We have previously reported the identification of a novel 17 kDa truncated isoform of the cyclin D2 activated in 13% of the leukemias induced by the Graffi murine leukemia retrovirus. Retroviral integration in the Gris1 locus causes an alternative splicing of the mouse cyclin D2 gene and expression of a truncated protein of 159 amino acids that is detected at high levels in the Gris1 tumors and also in normal mouse tissues mainly the brain and ovaries. A truncated form of the cyclin D2 was also found in human. We show here that both mouse- and human-truncated cyclin D2 are able to transform primary mouse embryo fibroblasts (MEF) when co-expressed with an activated Ras protein. The truncated cyclin D2 localizes only to the cytoplasm of transfected cells. It has retained the ability to interact with cyclin-dependent kinases (CDKs), although it is a poor catalyst of pRb phosphorylation. Interestingly, the presence of a similar, alternatively spliced cyclin D2 mRNA was also detected in some human brain tumors.


Subject(s)
Alternative Splicing/genetics , Cell Transformation, Neoplastic/genetics , Cyclins/genetics , Cyclins/metabolism , Animals , Cell Line, Tumor , Cells, Cultured , Cyclin D2 , Cyclins/biosynthesis , Humans , Mice , Subcellular Fractions/metabolism , Subcellular Fractions/physiology , ras Proteins/biosynthesis , ras Proteins/genetics , ras Proteins/metabolism
5.
Placenta ; 24(6): 648-57, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12828923

ABSTRACT

Adenylyl cyclase (AC) activity is ubiquitous in mammalian cells, and various forms of this enzyme exist that widely differ with regard to tissue distribution, abundance, and modes of regulation. Human placenta is made, among others, of cytotrophoblast cells and syncytiotrophoblasts. This latter is a polynucleate structure that originates from the differentiation of proliferative mononucleated cytotrophoblast cells, the placental stem cell, into syncytiotrophoblasts. In vitro, this differentiation process is associated with a concomitant increase in cellular levels of cAMP and enhanced expression of genes representative of syncytiotrophoblasts endocrine activity. Thus, in this study we evaluated the differential distribution of AC isoforms in cytotrophoblast cells and syncytiotrophoblasts by reverse transcription-polymerase chain reaction (RT-PCR) using total RNA or purified mRNA. Our results demonstrate that all membrane and soluble AC mRNA isoforms are present in both cell types. Interestingly in syncytiotrophoblasts, AC4 and AC8 mRNA are highly expressed, while AC1, AC2 mRNA are less abundant when compared to cytotrophoblast cells. Additionally, the soluble AC is expressed in both trophoblast cells, but its expression is greatly reduced in differentiated cells, syncytiotrophoblasts. The presence of these AC proteins in both cells was confirmed by Western blotting. Taken together, these data help us to characterize the different AC isoforms in human cytotrophoblast cells and syncytiotrophoblasts, and demonstrate that the AC isoforms expression seems to be mainly modulated in groups 1 and 2. Moreover, the important decrease of the soluble AC isoform in syncytiotrophoblasts as compared to cytotrophoblast cells could suggest an important role of this AC in the extravillous trophoblast formation.


Subject(s)
Adenylyl Cyclases/metabolism , Intracellular Membranes/enzymology , Trophoblasts/enzymology , Adenylyl Cyclases/genetics , Adult , Cells, Cultured , DNA Primers/chemistry , Female , Gene Expression Regulation, Developmental , Gene Expression Regulation, Enzymologic , Humans , Pregnancy , Protein Isoforms , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Trophoblasts/cytology
6.
Life Sci ; 70(6): 629-38, 2001 Dec 28.
Article in English | MEDLINE | ID: mdl-11833713

ABSTRACT

Apolipoprotein D (apoD), a 169 amino acid member of the lipocalin family, is thought to be a transporter of small, hydrophobic ligands. A panel of 10 anti-apoD monoclonal antibodies (mAbs) was prepared and characterized in order to define apoD structure-function relationships. An apoD epitope map was constructed based on reactivity of the mAbs with apoD fragments. Three mAbs react with epitopes between apoD residues 7-78, seven mAbs with epitopes between residues 128-169, one mAb recognizes an epitope that straddles residues 99-102 and one mAb is specific for an epitope composed of non-contiguous apoD residues. Several pairs of mAbs whose respective epitopes are widely separated in apoD primary structure can compete for binding to immobilized apoD. This would be consistent with the compact beta-barrel tertiary structure that apoD is thought to adopt. None of the mAbs block the interaction of apoD with pregnenolone, a putative physiological ligand for apoD.


Subject(s)
Apolipoproteins/chemistry , Biomarkers/chemistry , Immunochemistry/methods , Antibodies, Blocking/immunology , Antibodies, Monoclonal/immunology , Apolipoproteins/immunology , Apolipoproteins D , Binding, Competitive , Epitope Mapping , Humans , Ligands , Pregnenolone/immunology , Protein Structure, Tertiary , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , beta-Galactosidase/immunology
7.
Biochim Biophys Acta ; 1517(1): 164-70, 2000 Dec 15.
Article in English | MEDLINE | ID: mdl-11118632

ABSTRACT

The mouse Fli-1 proto-oncogene is activated by proviral integration of four murine leukemia retroviruses and its human counterpart is translocated (11,22) in Ewing tumors. We have identified two alternative exons 1 by RACE analysis from a human neuroectodermal tumor. Exons 1a and 1b are located respectively 1.3 and 2.5 kb upstream from the published exon 1. Translation of these alternative messengers is predicted to generate very similar proteins. The sequence upstream from exon 1b showed functional promoter activity. Exon 1b was not conserved in the mouse but was detected in every analyzed human cell, whereas exon 1a was present only in a subset of them and also in various mouse cell lines. These results suggest that both mouse and human Fli-1 gene expression might be under the control of several independent promoter regions.


Subject(s)
DNA-Binding Proteins/genetics , Exons , Proto-Oncogene Proteins , Trans-Activators/genetics , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Humans , Mice , Molecular Sequence Data , Neuroectodermal Tumors/genetics , Promoter Regions, Genetic , Proto-Oncogene Mas , Proto-Oncogene Protein c-fli-1 , Reverse Transcriptase Polymerase Chain Reaction
8.
Biochemistry ; 39(51): 16084-91, 2000 Dec 26.
Article in English | MEDLINE | ID: mdl-11123936

ABSTRACT

To determine the importance of hepatic apolipoprotein (apo) E in lipoprotein metabolism, HepG2 cells were transfected with a constitutive expression vector (pRc/CMV) containing either the complete or the first 474 base pairs of the human apoE cDNA inserted in an antisense orientation, for apoE gene inactivation, or the full-length human apoE cDNA inserted in a sense orientation for overexpression of apoE. Stable transformants were obtained that expressed 15, 24, 226, and 287% the apoE level of control HepG2 cells. The metabolism of low-density lipoprotein (LDL) and high-density lipoprotein-3 (HDL(3)), two lipoprotein classes following both holoparticle and cholesteryl esters (CE)-selective uptake pathways, was compared between all these cells. LDL-protein degradation, an indicator of the holoparticle uptake, was greater in low apoE expressing cells than in control or high expressing cells, while HDL(3)-protein degradation paralleled the apoE levels of the cells (r(2) = 0.989). LDL- and HDL(3)-protein association was higher in low apoE expressing cells compared to control cells. In opposition, LDL- and HDL(3)-CE association was not different from control cells in low apoE expressing cells but rose in high apoE expressing cells. In consequence, the CE-selective uptake (CE/protein association ratio) was positively correlated with the level of apoE expression in all cells for both LDL (r(2) = 0.977) and HDL(3) (r(2) = 0.998). We also show that, although in normal and low apoE expressor cells, 92% of LDL- and 80% HDL(3)-CE hydrolysis is sensitive to chloroquine suggesting a pathway linked to lysosomes for both lipoproteins, cells overexpressing apoE lost 60% of chloroquine-sensitive HDL(3)-CE hydrolysis without affecting that of LDL-CE. Thus, the level of apoE expression in HepG2 cells determines the fate of LDL and HDL(3).


Subject(s)
Apolipoproteins E/biosynthesis , Lipoproteins, HDL/metabolism , Lipoproteins, LDL/metabolism , Tumor Cells, Cultured/metabolism , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Carcinoma, Hepatocellular/metabolism , Chloroquine/pharmacology , Cholesterol Esters/metabolism , Cholesterol, HDL/metabolism , Genetic Vectors/metabolism , Humans , Hydrolysis/drug effects , Intracellular Fluid/metabolism , Protein Binding/genetics , Temperature , Transfection , Tritium
9.
Biochim Biophys Acta ; 1482(1-2): 185-98, 2000 Oct 18.
Article in English | MEDLINE | ID: mdl-11058760

ABSTRACT

Apolipoprotein D (apoD) is a 29-kDa glycoprotein that is primarily associated with high density lipoproteins in human plasma. It is an atypical apolipoprotein and, based on its primary structure, apoD is predicted to be a member of the lipocalin family. Lipocalins adopt a beta-barrel tertiary structure and transport small hydrophobic ligands. Although apoD can bind cholesterol, progesterone, pregnenolone, bilirubin and arachidonic acid, it is unclear if any, or all of these, represent its physiological ligands. The apoD gene is expressed in many tissues, with high levels of expression in spleen, testes and brain. ApoD is present at high concentrations in the cyst fluid of women with gross cystic disease of the breast, a condition associated with increased risk of breast cancer. It also accumulates at sites of regenerating peripheral nerves and in the cerebrospinal fluid of patients with neurodegenerative conditions, such as Alzheimer's disease. ApoD may, therefore, participate in maintenance and repair within the central and peripheral nervous systems. While its role in metabolism has yet to be defined, apoD is likely to be a multi-ligand, multi-functional transporter. It could transport a ligand from one cell to another within an organ, scavenge a ligand within an organ for transport to the blood or could transport a ligand from the circulation to specific cells within a tissue.


Subject(s)
Apolipoproteins/genetics , Animals , Apolipoproteins/chemistry , Apolipoproteins/metabolism , Apolipoproteins D , Gene Expression , Humans , Nervous System/metabolism , Protein Conformation , Tissue Distribution
10.
J Biol Chem ; 275(10): 7109-16, 2000 Mar 10.
Article in English | MEDLINE | ID: mdl-10702278

ABSTRACT

Monoclonal antibody 2E8 is specific for an epitope that coincides with the binding site of the low density lipoprotein receptor (LDLR) on human apoE. Its reactivity with apoE variants resembles that of the LDLR: it binds well with apoE3 and poorly with apoE2. The heavy chain complementarity-determining region (CDRH) 2 of 2E8 shows homology to the ligand-binding domain of the LDLR. To define better the structural basis of the 2E8/apoE interaction and particularly the role of electrostatic interactions, we generated and characterized a panel of 2E8 variants. Replacement of acidic residues in the 2E8 CDRHs showed that Asp(52), Glu(53), and Asp(56) are essential for high-affinity binding. Although Asp(31) (CDRH1), Glu(58) (CDRH2), and Asp(97) (CDRH3) did not appear to be critical, the Asp(97) --> Ala variant acquired reactivity with apoE2. A Thr(57) --> Glu substitution increased affinity for both apoE3 and apoE2. The affinities of wild-type 2E8 and variants for apoE varied inversely with ionic strength, suggesting that electrostatic forces contribute to both antigen binding and isoform specificity. We propose a model of the 2E8.apoE immune complex that is based on the 2E8 and apoE crystal structures and that is consistent with the apoE-binding properties of wild-type 2E8 and its variants. Given the similarity between the LDLR and 2E8 in terms of specificity, the LDLR/ligand interaction may also have an important electrostatic component.


Subject(s)
Antibodies, Monoclonal/metabolism , Apolipoproteins E/metabolism , Receptors, LDL/metabolism , Antibodies, Monoclonal/chemistry , Antigen-Antibody Complex/chemistry , Cysteamine/pharmacology , Humans , Immunoglobulin Heavy Chains/metabolism , Models, Molecular , Mutagenesis, Site-Directed , Protein Structure, Tertiary , Receptors, LDL/immunology , Static Electricity , Structure-Activity Relationship
11.
Protein Sci ; 8(11): 2392-8, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10595541

ABSTRACT

Cholesteryl ester transfer protein (CETP) plays an important role in plasma lipoprotein metabolism through its ability to transfer cholesteryl ester, triglyceride, and phospholipid between lipoproteins. CETP is a member of a gene family that also includes bactericidal/permeability-increasing protein (BPI). The crystal structure of BPI shows it to be composed of two domains that share a similar structural fold that includes an apolar ligand-binding pocket. As structurally important residues are conserved between BPI and CETP, it is thought that CETP and BPI may have a similar overall conformation. We have previously proposed a model of CETP structure based on the binding characteristics of anti-CETP monoclonal antibodies (mAbs). We now present a refined epitope map of CETP that has been adapted to a structural model of CETP that uses the atomic coordinates of BPI. Four epitopes composed of CETP residues 215-219, 219-223, 223-227, and 444-450, respectively, are predicted to be situated on the external surface of the central beta-sheet and a fifth epitope (residues 225-258) on an extended linker that connects the two domains of the molecule. Three other epitopes, residues 317-331, 360-366, and 393-410, would form part of the putative carboxy-terminal beta-barrel. The ability of the corresponding mAbs to compete for binding to CETP is consistent with the proximity of the respective epitopes in the model. These results thus provide experimental evidence that is consistent with CETP and BPI having similar surface topologies.


Subject(s)
Blood Proteins/chemistry , Carrier Proteins/chemistry , Glycoproteins , Membrane Proteins , Antibodies, Monoclonal , Antimicrobial Cationic Peptides , Apolipoproteins/chemistry , Blood Bactericidal Activity , Blood Proteins/genetics , Carrier Proteins/genetics , Cholesterol Ester Transfer Proteins , Computer Graphics , Epitopes/chemistry , Humans , Immunohistochemistry/methods , Models, Molecular , Protein Structure, Secondary , Protein Structure, Tertiary , Recombinant Fusion Proteins/chemistry , Restriction Mapping
12.
Biochemistry ; 38(44): 14524-33, 1999 Nov 02.
Article in English | MEDLINE | ID: mdl-10545174

ABSTRACT

The contribution of the amphipathic alpha-helices of apoA-I toward lipid efflux from human skin fibroblasts and macrophage was examined. Four apoA-I mutants were designed, each by deletion of a pair of predicted adjacent helices. Three mutants lacked two consecutive central alpha-helices [Delta(100-143), Delta(122-165), and Delta(144-186)], whereas the final mutant lacked the C-terminal domain [Delta(187-243)]. When compared to recombinant wild-type apoA-I and mutants with central domain deletions, Delta(187-243) exhibited a marked reduction in its ability to promote either cholesterol or phospholipid efflux from THP-1 macrophages. This mutant also demonstrated a decreased ability to bind lipids and to form lipoprotein complexes. In contrast, the four mutants and apoA-I equally supported cholesterol efflux from fibroblasts, albeit with a reduced capacity when compared to macrophages. Delta(187-243) bound poorly to the macrophage cell surface when compared to apoA-I, and competitive binding studies with the central domain and C-terminal deletions mutants showed that only Delta(187-243) did not compete effectively with [(125)I]apoA-I. Omission of PMA during cholesterol loading enhanced cholesterol efflux to both apoA-I (1.5-fold) and the C-terminal deletion mutant (2.5-fold). Inclusion of the Sandoz ACAT inhibitor (58-035) during loading and, in the absence of PMA, increased and equalized cholesterol efflux to apoA-I and Delta(187-243). Surprisingly, omission of PMA during cholesterol loading had minimal effects on the binding of apoA-I or Delta(187-243) to the THP-1 cell surface. Overall, these results show that cholesterol efflux from cells such as fibroblasts does not require any specific sequence between residues 100 and 243 of apoA-I. In contrast, optimal cholesterol efflux in macrophages requires binding of the C-terminal domain of apoA-I to a cell surface-binding site and the subsequent translocation of intracellular cholesterol to an efflux-competent pool.


Subject(s)
Apolipoprotein A-I/chemistry , Apolipoprotein A-I/metabolism , Lipid Metabolism , Macrophages/metabolism , Amides/pharmacology , Apolipoprotein A-I/genetics , Base Sequence , Cell Membrane/metabolism , Cells, Cultured , Cholesterol/metabolism , DNA, Complementary/genetics , Enzyme Inhibitors/pharmacology , Fibroblasts/metabolism , Humans , Macrophages/drug effects , Organosilicon Compounds/pharmacology , Phospholipids/metabolism , Protein Binding , Protein Structure, Secondary , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Deletion , Sterol O-Acyltransferase/antagonists & inhibitors , Tetradecanoylphorbol Acetate/pharmacology
13.
Virology ; 264(1): 181-6, 1999 Nov 10.
Article in English | MEDLINE | ID: mdl-10544143

ABSTRACT

The BL/VL(3) Kaplan radiation leukemia virus (RadLV-VL(3)) is a nondefective retrovirus that induces T cell lymphomas in several strains of mice. By using DNA probes derived from RadLV/VL(3) provirus-flanking sequences cloned from the BL/VL(3) cell line, we identified a DNA region rearranged in 5 of 19 tumors analysed (25%). All proviruses were integrated in the same 5'-to-3' orientation in a small DNA region called Kis1 (Kaplan integration site 1). This region was localized on distal mouse chromosome 2 in a region not previously identified as important to lymphomagenesis. The cells rearranged at the Kis1 locus represent a clonal subpopulation of the clonal tumor masses examined, indicating a probable role of Kis1 in tumor progression.


Subject(s)
Chromosome Mapping , Lymphoma, T-Cell/genetics , Lymphoma, T-Cell/virology , Proviruses/genetics , Radiation Leukemia Virus/genetics , Virus Integration , Animals , Crosses, Genetic , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Muridae , Restriction Mapping , Retroviridae Infections/genetics , Retroviridae Infections/virology , T-Lymphocytes/virology , Tumor Cells, Cultured , Tumor Virus Infections/genetics , Tumor Virus Infections/virology
14.
Oncogene ; 18(40): 5535-45, 1999 Sep 30.
Article in English | MEDLINE | ID: mdl-10523830

ABSTRACT

Fli-1 is a proto-oncogene which is rearranged in tumors induced by three different retroviruses, Cas-Br-E, F-MuLV, and 10A1. This gene is a member of the Ets gene family, a class of transcription factors that recognize and bind to a DNA motif known as the Ets binding site (EBS). Our laboratory has previously cloned and characterized the promoter region of both human and mouse Fli-1 genes. We had then identified several regulatory elements conserved between the two species. Two of them, an exon 1 GATA/EBS dual element and an EBS element located in the 5' end of intron 1, were analysed in the present study. EMSA analysis performed with nuclear extracts from different cell lines showed that the EBS element in intron 1 (EBSi) was bound by one potential Ets-related ubiquitous factor. The GATA/EBS element was bound by several factors that seemed Ets-related, one of which was found to be specifically expressed in hematopoietic cells. the GATA/EBS dual element was thus chosen for further analysis. A human Fli-1-derived genomic fragment containing the GATA/EBS led to enhanced transcription when positioned upstream of the SV40 promoter in the erythroleukemic HEL cell line. In addition, an increasing number of GATA/EBS oligonucleotides upstream of this same promoter resulted in a copy number-dependent increase in luciferase activity which was greatly reduced when the EBS consensus sequence was mutated. One of the factors binding to the GATA/EBS region was identified to be Spi-1 by supershift analysis and was also shown to bind to the EBS element of the human Ets-2 gene. Supershift analysis also demonstrated the binding of the GATA-1 factor to the GATA/EBS dual element. Our results suggest that Spi-1 and GATA-1 might play a key role in the regulation of Fli-1.


Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Exons/genetics , Proto-Oncogene Proteins/metabolism , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factors/metabolism , Transcription, Genetic , Animals , CHO Cells , COS Cells , Chlorocebus aethiops , Consensus Sequence , Cricetinae , Cricetulus , DNA, Antisense/genetics , Erythroid-Specific DNA-Binding Factors , GATA1 Transcription Factor , Genes, Reporter , Humans , Introns/genetics , Leukemia/pathology , Mice , Promoter Regions, Genetic , Protein Binding , Proto-Oncogene Mas , Proto-Oncogene Protein c-fli-1 , Recombinant Fusion Proteins/biosynthesis , Regulatory Sequences, Nucleic Acid , Sequence Alignment , Sequence Homology, Nucleic Acid , Simian virus 40/genetics , Tumor Cells, Cultured
15.
Mutat Res ; 444(2): 427-39, 1999 Aug 18.
Article in English | MEDLINE | ID: mdl-10521683

ABSTRACT

Certain environmental contaminants found in marine mammals have been shown to cause DNA damage and cancer. The micronuclei (MN), sister chromatid exchange (SCE) and/or chromosome aberration (CA) assays were used to assess baseline (spontaneous) levels of DNA damage in blood lymphocytes of individuals of the relatively healthy and lightly contaminated Arctic beluga whale (Delphinapterus leucas), Sarasota Bay, FL, bottlenose dolphin (Tursiops truncatus) and Northwestern Atlantic grey (Halichoerus grypus) and harp (Phoca groenlandicus) seal populations. MN cell (MNC) frequencies ranged between 2 and 14/1000 binucleated (BN) cells and were statistically similar between species. In bottlenose dolphins, MNC frequency was correlated with age and was significantly higher in females than in males. No intraspecific variation in MNC frequency was found in beluga whales. Intraspecific variation was not tested in seals due to the small sample size. Frequencies of SCEs and total CAs, excluding gaps, ranged, respectively, between 1 and 15 SCE(s)/per cell and 4-6 CAs/100 cells in beluga whales. SCE and CA frequencies did not vary with age or sex in beluga whales. The MN, SCE and CA assays were found to be practical tools for the detection of DNA damage in marine mammals and could be used in the future to compare DNA damage between relatively lightly and highly contaminated populations.


Subject(s)
DNA Damage , Dolphins/genetics , Seals, Earless/genetics , Whales/genetics , Animals , Biomarkers , Chromosome Aberrations , Female , Male , Micronucleus Tests , Sister Chromatid Exchange
16.
Brain Res Mol Brain Res ; 70(1): 26-35, 1999 Jun 18.
Article in English | MEDLINE | ID: mdl-10381540

ABSTRACT

Apolipoprotein (apo) D is a member of the lipocalin family of proteins. Although its physiological function is unknown, apoD is thought to transport one or more small hydrophobic ligands. A second apolipoprotein, apoE is known to play an important role in lipid transport, and apoE genetic polymorphism has been shown to be associated with susceptibility to Alzheimer's disease. Both apoD and apoE are expressed in the central nervous system (CNS) and both proteins accumulate at sites of peripheral nerve injury due to increased local synthesis. The two proteins may have overlapping or complementary functions within nervous tissue. In order to define the role of apoD within the CNS, we have studied the regional distribution of apoD and apoE mRNA and protein within the normal rat brain and the changes in apoD and apoE expression in the hippocampus of rats after entorhinal cortex lesion (EC lesion). Within the brains of normal rats, apoD expression in the hippocampus was as high as 180-fold that of the liver. ApoD mRNA levels in other areas of the rat brain ranged from 40 to 120 times the hepatic levels. The distribution of apoE gene expression within the brain was similar to that of apoD, but was much lower than hepatic apoE expression. When rats were subjected to EC lesion, the apoD message increased by 54% at 4 days post lesion (DPL) in the ipsilateral region of hippocampus while apoE mRNA levels (ipsilateral and contralateral) decreased by 43%. At 6 to 8 DPL apoD mRNA in the ipsilateral hippocampus remained elevated (42% above controls) whereas the apoE mRNA levels increased to about 15% above those of controls. At 14 and 31 DPL, both apoD and apoE expression was similar to controls. The increase in immunoreactive apoD in hippocampal extracts was more dramatic. At 1 DPL, immunoreactive apoD levels were already 16-fold higher than those in extracts of non-lesioned animals and, at 31 DPL, levels were still 8-fold higher than those of control animals. Finally, we have demonstrated that the levels of apoD in the brains of apoE-deficient mice are 50-fold those of wildtype control mice. ApoD clearly has an important function within the CNS in both normal and pathological situations.


Subject(s)
Apolipoproteins E/biosynthesis , Apolipoproteins/biosynthesis , Entorhinal Cortex/injuries , Gene Expression Regulation , Hippocampus/metabolism , Nerve Tissue Proteins/biosynthesis , Animals , Apolipoproteins/genetics , Apolipoproteins/physiology , Apolipoproteins D , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Astrocytes/metabolism , Blotting, Northern , Cerebellum/metabolism , Electric Injuries/metabolism , Entorhinal Cortex/physiopathology , Frontal Lobe/metabolism , Liver/metabolism , Male , Mice , Mice, Knockout , Nerve Tissue Proteins/genetics , Organ Specificity , RNA, Messenger/biosynthesis , Rats , Rats, Inbred F344
17.
Protein Expr Purif ; 16(1): 84-90, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10336864

ABSTRACT

We report the bacterial expression and the purification of a monoclonal antibody (mAb) specific for an epitope that coincides with the LDL receptor (LDLr)-binding domain of human apolipoprotein E (apoE). This antibody resembles the LDLr in its primary structure and its specificity for apoE variants. The recombinant Fab (rFab) fragment of mAb 2E8, consisting of the entire light chain and the Fd portion of the heavy chain, was expressed in Escherichia coli and purified to homogeneity. Purification was facilitated by including a five-histidine carboxyl-terminal extension on the Fd chain. A 5- to 10-fold difference in yield of the antibody was observed when the plasmid was expressed in two different strains of E. coli. Typically 2-6 mg of rFab per liter of culture medium was recovered in the periplasm of the TG1 strain and less than 1 mg was recovered in the periplasm of the XL1-Blue strain. Culture temperatures above 35 degrees C or inclusion of sucrose in the medium reduced rFab yields. The 2E8 rFab was indistinguishable from Fab prepared from 2E8 hybridoma-generated IgG with respect to its affinity and fine specificity. We are using this system to express a panel of 2E8 variant Fabs that will be used as probes to establish the structural features responsible for the binding of apoE to the LDLr.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/genetics , Apolipoproteins E/immunology , Apolipoproteins E/metabolism , Immunoglobulin Fab Fragments/biosynthesis , Immunoglobulin Fab Fragments/genetics , Receptors, LDL/metabolism , Animals , Antibodies, Monoclonal/isolation & purification , Antibody Specificity , Apolipoproteins E/chemistry , Base Sequence , Binding Sites , DNA Primers/genetics , Epitopes , Escherichia coli/genetics , Gene Expression , Genetic Variation , Humans , Immunoglobulin Fab Fragments/isolation & purification , In Vitro Techniques , Mice
18.
J Virol ; 73(5): 4439-42, 1999 May.
Article in English | MEDLINE | ID: mdl-10196342

ABSTRACT

The Graffi murine leukemia virus (MuLV) is a nondefective retrovirus that induces granulocytic leukemia in BALB/c and NFS mice. To identify genes involved in Graffi MuLV-induced granulocytic leukemia, tumor cell DNAs were examined for genetic alterations at loci described as common proviral integration sites in MuLV-induced myeloid, lymphoid, and erythroid leukemias. Southern blot analysis revealed rearrangements in c-myc, Fli-1, Pim-1, and Spi-1/PU.1 genes in 20, 10, 3.3, and 3.3% of the tumors tested, respectively. These results demonstrate for the first time the involvement of those genes in granulocytic leukemia.


Subject(s)
DNA-Binding Proteins/genetics , Leukemia Virus, Murine/genetics , Leukemia, Myeloid/genetics , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins/genetics , Trans-Activators/genetics , Virus Integration/genetics , Animals , Gene Rearrangement , Leukemia, Myeloid/virology , Mice , Mice, Inbred BALB C , Oncogenes , Proto-Oncogene Protein c-fli-1 , Proto-Oncogene Proteins c-pim-1 , Proviruses/genetics
19.
Mutat Res ; 439(1): 87-95, 1999 Feb 02.
Article in English | MEDLINE | ID: mdl-10029683

ABSTRACT

Beluga whales (Delphinapterus leucas) inhabiting the St. Lawrence estuary are highly contaminated with environmental pollutants and have a high incidence of cancer. Environmental contaminants may be partly responsible for the high cancer incidence observed in this population. DNA damage plays an important role in the development of cancer. The micronuclei (MN) assay was used to test the genotoxic potential of organochlorine (OC) pesticides with and without external metabolic factor in skin fibroblasts of an Arctic beluga whale. Toxaphene, chlordane and p,p'-DDT induced significant (p<0. 05) concentration-response increases of micronucleated cells (MNCs). Statistically significant increases in MNCs, ranging from 1.7- to 5-folds when compared to control cultures, were observed for 0.05, 0. 5, 5 and 10 microg/ml toxaphene, 2, 5 and 10 microg/ml chlordane and 10 and 15 microg/ml p,p'-DDT. Presence of exogeneous metabolic factor (S9) completely abolished the MN induction potency of chlordane and p,p'-DDT, and toxaphene induced MN formation at higher concentrations (0.5 microg/ml) than without S9 mix. The ecotoxicological significance of MN induction by low concentrations of toxaphene is unknown and do not imply that toxaphene is involved in the etiology of cancer in St. Lawrence beluga whales. However, because of the known genotoxicity of toxaphene and the long lifespan of beluga whales, it cannot be excluded that toxaphene may pose a long-term genetic hazard to the more contaminated whales of this population.


Subject(s)
Carcinogens/toxicity , Environmental Pollutants/toxicity , Insecticides/toxicity , Micronuclei, Chromosome-Defective/drug effects , Whales/genetics , Animals , Canada , Cell Cycle/drug effects , Chlordan/toxicity , DDT/toxicity , Fibroblasts , Micronuclei, Chromosome-Defective/genetics , Micronucleus Tests , Mutagenicity Tests , Mutagens/toxicity , Pesticides/toxicity , Toxaphene/toxicity
20.
J Neurochem ; 71(4): 1643-50, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9751198

ABSTRACT

Apolipoprotein D (apoD) is a member of the lipocalin family of proteins. Most members of this family are transporters of small hydrophobic ligands, although in the case of apoD, neither its physiological function(s) nor its putative ligand(s) have been unequivocally identified. In humans, apoD is expressed in several tissues, including the CNS, and its synthesis is greatly increased during regeneration of rat peripheral nerves. As apoD may have an important function in the nervous system and, particularly, in nerve regeneration, we measured immunoreactive apoD levels in the hippocampus and in CSF of patients with either Alzheimer's disease (AD) or other neuropathologies. In parallel, we determined the concentrations of apolipoprotein E (apoE), another apolipoprotein also implicated in nerve regeneration and in the etiology of AD. Levels of apoD but not apoE were increased in the hippocampus of AD patients compared with controls. ApoD concentrations, as determined by radioimmunoassay, were significantly increased in the CSF of AD patients (4.23 +/- 1.58 microg/ml) and patients with other pathologies (3.29 +/- 1.35 microg/ml) compared with those in the CSF of normal subjects (1.15 +/- 0.71 microg/ml). Although the differences were smaller than for apoD, the mean apoE concentrations in the CSF of both groups of patients were also significantly higher than those of controls. In AD patients, apoD, but not apoE, levels in CSF and hippocampus increased as a function of inheritance of the epsilon4 apoE allele. This study therefore demonstrates that increased apoD levels in the hippocampus and in CSF are a marker of neuropathology, including that associated with AD, and are independent of apoE concentrations.


Subject(s)
Alzheimer Disease/cerebrospinal fluid , Apolipoproteins/cerebrospinal fluid , Apolipoproteins/metabolism , Hippocampus/metabolism , Aged , Aged, 80 and over , Alzheimer Disease/metabolism , Apolipoproteins D , Apolipoproteins E/cerebrospinal fluid , Apolipoproteins E/metabolism , Biomarkers/cerebrospinal fluid , Female , Humans , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...